Brief: Alpha Cognition Announces Partner China Medical System Has NDA Accepted In China For The Review Of Zunveyl® (Benzgalantamine) For Alzheimer’S Disease
29/07/2025 15:01
July 29 (Reuters) - Alpha Cognition Inc ACOG.O: ALPHA COGNITION ANNOUNCES PARTNER CHINA MEDICAL SYSTEM HAS NDA ACCEPTED IN CHINA FOR THE REVIEW OF ZUNVEYL® (BENZGALANTAMINE) FOR ALZHEIMER’S DISEASE Source text: ID:nBw80ZYzBa Further company coverage: ACOG.O ((Reuters.Briefs@thomsonreuters.com;))